Yooni Blair, MD
Urology · Ann Arbor, MINPI 1922444389
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (53.1%), consulting fees and food and beverage — rather than concentrated in one kind of arrangement. 6 manufacturers reported payments, led by Coloplast at 59.6% of the total. Reporting peaked in 2020 at $11,704 and has fallen 76.6% since, to $2,735 in 2025. Among urology clinicians in MI with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 85 payments — averaging $259.36 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Coloplast$13K
- Boston Scientific$8K
- Endo USA, Inc.$500
- AbbVie$59
- Antares Pharma, Inc.$50
- Laborie Medical Technologies Corp.$49
What the payments were for
- Consulting fees$3,65017%
- Speaking & faculty fees$11,70453%
- Grants$2,0009%
- Travel & lodging$2,0139%
- Food & beverage$2,67912%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Coloplast | 18 | $13,135 |
| Boston Scientific | 63 | $8,252 |
| Endo USA, Inc. | 1 | $500 |
| AbbVie | 1 | $59 |
| Antares Pharma, Inc. | 1 | $50 |
| Laborie Medical Technologies Corp. | 1 | $49 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- TITAN$12,865
- AMS$4,786
- GENERAL ERECTILE DYSFUNCTION$2,234
How this compares
$22,046 in reported general payments places this provider in the 90th percentile of 400 urology providers in Michigan.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MyrbetriqMirabegron | 43 | $43,048 |
| GemtesaVibegron | 11 | $8,228 |
| Tolterodine Tartrate ErTolterodine Tartrate | 30 | $2,632 |
| Tamsulosin Hcl | 30 | $682 |
| Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip | 14 | $208 |
| Cephalexin | 37 | $114 |
Paid to pharmacies, not to this prescriber.
Other urology in Ann Arbor
- William RobertsAnn Arbor$973K
- Khurshid GhaniAnn Arbor$413K
- Casey DauwAnn Arbor$188K
- Bahaa MalaebAnn Arbor$98K
- James ClemensAnn Arbor$63K
- Todd MorganAnn Arbor$34K
- Stephanie KielbAnn Arbor$26K
- John StoffelAnn Arbor$17K
- Lindsey HerrelAnn Arbor$15K
- Ashok ReddySterling Heights$4.9M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.